Numerous scientific and clinical studies have demonstrated that PD-(L)1 antibodies produce significant inhibition of tumor cell proliferation through activating immune cells in the tumor immune microenvironment (TIME) in various tumors (5). This evidence concerns the gene CD274 and neoplasm.